These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 18359622

  • 1. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA.
    Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, Bélanger P, Chaussade V, Deloche C, Leclaire J.
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):1-9. PubMed ID: 18359622
    [Abstract] [Full Text] [Related]

  • 2. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

  • 3. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women.
    Labrie F, Bélanger A, Labrie C, Candas B, Cusan L, Gomez JL.
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):57-69. PubMed ID: 17627814
    [Abstract] [Full Text] [Related]

  • 4. Metabolism of DHEA in postmenopausal women following percutaneous administration.
    Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J.
    J Steroid Biochem Mol Biol; 2007 Feb; 103(2):178-88. PubMed ID: 17084625
    [Abstract] [Full Text] [Related]

  • 5. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur É, other participating members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y, Labrie F, Gonthier R, Simard JN, Bergeron D, Martel C, Vaillancourt M, Montesino M, Lavoie L, Archer DF, Balser J, Moyneur E, other participating Members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
    [Abstract] [Full Text] [Related]

  • 7. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
    Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL.
    J Steroid Biochem Mol Biol; 2013 Nov; 138():359-67. PubMed ID: 23954500
    [Abstract] [Full Text] [Related]

  • 8. Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA.
    Ke Y, Gonthier R, Simard JN, Archer D, Lavoie L, Martel C, Vaillancourt M, Labrie F.
    Horm Mol Biol Clin Investig; 2015 Dec; 24(3):117-29. PubMed ID: 26509785
    [Abstract] [Full Text] [Related]

  • 9. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
    Kalogera E, Pistos C, Provatopoulou X, Athanaselis S, Spiliopoulou C, Gounaris A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec 01; 940():24-34. PubMed ID: 24140653
    [Abstract] [Full Text] [Related]

  • 10. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
    Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2396-402. PubMed ID: 9253307
    [Abstract] [Full Text] [Related]

  • 11. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2578-85. PubMed ID: 9253337
    [Abstract] [Full Text] [Related]

  • 12. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 01; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 13. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?
    Labrie F, Martel C, Balser J.
    Menopause; 2011 Jan 01; 18(1):30-43. PubMed ID: 20683211
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.
    Acacio BD, Stanczyk FZ, Mullin P, Saadat P, Jafarian N, Sokol RZ.
    Fertil Steril; 2004 Mar 01; 81(3):595-604. PubMed ID: 15037408
    [Abstract] [Full Text] [Related]

  • 15. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.
    Bélanger A, Brochu M, Cliche J.
    J Clin Endocrinol Metab; 1986 May 01; 62(5):812-5. PubMed ID: 2937801
    [Abstract] [Full Text] [Related]

  • 16. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey.
    Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F.
    J Clin Endocrinol Metab; 2003 Sep 01; 88(9):4293-302. PubMed ID: 12970301
    [Abstract] [Full Text] [Related]

  • 17. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ, Saxena T, Lobo RA.
    J Steroid Biochem Mol Biol; 2014 Jan 01; 139():73-7. PubMed ID: 24121067
    [Abstract] [Full Text] [Related]

  • 18. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S, Massien C, Lahlou N, Roger M, Debuire B, Diquet B, Chatellier G, Azizi M, Faucounau V, Porchet H, Forette F, Baulieu EE.
    J Clin Endocrinol Metab; 2000 Sep 01; 85(9):3208-17. PubMed ID: 10999810
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women.
    Stanczyk FZ, Slater CC, Ramos DE, Azen C, Cherala G, Hakala C, Abraham G, Roy S.
    Menopause; 2009 Sep 01; 16(2):272-8. PubMed ID: 19098687
    [Abstract] [Full Text] [Related]

  • 20. Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate.
    Brochu M, Bélanger A, Dupont A, Cusan L, Labrie F.
    J Steroid Biochem; 1987 Dec 01; 28(6):619-22. PubMed ID: 2961945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.